Overview


According to FutureWise analysis the market for Antifungal Treatment in 2023 is US$ 15.91 billion, and is expected to reach US$ 21.7 billion by 2031 at a CAGR of 4.00%.

Antifungal medications, also known as actinomycetes, are specialized drugs designed to fight against fungal infections by killing the fungi or inhibiting their growth. They can affect various body parts, including the respiratory, circulatory, skin, and nails. They exist in different forms, such as yeasts, Molds, or a combination of both, and reproduce through tiny spores in soil or airborne. Some fungi can be seen naturally occurring in the human body, like Candida yeast, residing on the skin, digestive system, and the female reproductive system. While fungal infections can affect anyone, individuals with weak immune systems, such as those with autoimmune disorders, AIDS, cancer, or those who have undergone organ or stem cell transplants or surgeries, are at higher risk and can turn into life-threatening fungal infections termed opportunistic infections. 

Antifungals are crucial in treating various ailments, from common conditions like athlete's foot and ringworm to more severe illnesses like meningitis and blood infections. They work by eliminating the fungus, preventing its growth, or hindering its multiplication. Various classes and types of antifungal medications are available, and their treatment choice depends on the healthcare provider based on the specific infection and its severity. Antifungal medications can be administered through injections, oral pills, topical creams, or vaginal suppositories, with both over-the-counter and prescription options available, depending on the situation.

FutureWise Market Research has published a report that provides an insightful analysis of Antifungal Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Antifungal Treatment Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Pfizer, Inc.
  • Astellas
  • Novartis AG.
  • Sanofi
  • Merck & Co., Inc.
  • Bayer AG
  • Abbott

(Note: The list of the major players will be updated with the latest market scenario and trends)

 Recent Development in Antifungal Treatment Market:

  • In April 2022, Mycovia Pharmaceuticals, Inc. achieved a significant milestone as the United States Food and Drug Administration (US FDA) approved VIVJOA (oteseconazole capsules). VIVJOA is an azole antifungal medication specifically designed to lower the occurrence of recurrent vulvovaginal candidiasis (RVVC) in females. This approval is particularly noteworthy as it marks the first FDA-approved treatment for this condition and the inaugural product to receive FDA endorsement from Mycovia Pharmaceuticals, Inc.
  • Moreover, in June 2022, Apex Labs introduced a cutting-edge medical solution named Supra Bioavailable Itraconazole 65 and 130 mg capsules. These capsules are a potent therapeutic option in the battle against fungal infections. What sets these capsules apart is their remarkable ability to deliver a higher concentration (90 percent) of active medication to the body's biological system while utilizing a lower dosage. This innovation not only ensures greater consistency between individuals but also holds the potential to enhance the effectiveness of fungal infection management.

Emerging new drug-resistant fungal strains are increasing the demand in the antifungal treatment market. Increased incidence of autoimmune disease, cancer, and AIDS/HIV can contribute to the higher prevalence of fungal infections, thus propelling the demand for antifungal medications. Also, immunocompromised patients who have undergone extensive surgeries or organ transplants are more prone to these fungal infections, fueling the market growth. Rise in the large patient pool of the senior population, which is more prone to fungal infections. Government and non-government bodies are taking initiatives by organizing campaigns, spreading awareness among individuals, and providing free medicinal kits to serve the maximum population. Research and developments are being done on this antifungal treatment, and the government is raising funds for these, thus driving the market.

However, significant constraints are there that are hampering the market. The high cost of the treatment and the medicines deter the patient from continuing the treatment procedures and medications. Some individuals have become resistant to antifungal-specific drugs, which shows the fungus's potential evolution and makes the treatment more challenging.

By Drugs Class

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Pyrimidines
  • Others

By Therapeutic Indication

  • Systemic
  • Candidiasis
  • Cryptococcosis
  • Prophylactic Use Of Antifungals
  • Coccidioidomycosis

By Pathogen

  • Candida
  • Aspergillus
  • Cryptococcus
  • Coccidioides Immitis
  • Zygomycetes
  • Trichophyton

By End User

  • Hospitals
  • Clinics
  • Dermatology Clinics

By Region

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America is anticipated to account for the largest share of the market in the forecast period due to a rise in the prevalence of fungal infections, the increased patient pool of geriatric patients who are more prone to infections, and also due to immunocompromised individuals who get easily affected by these fungal infections. In addition, government and non-government bodies are raising funds for research and development to enhance the treatment modalities and new advanced technological interventions to ease the procedure. Also, these organizations are creating awareness by organizing campaigns and driving the market in this region. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Antifungal Treatment Market By Drugs Class, By Therapeutic Indication, By Pathogen, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Antifungal Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antifungal Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Antifungal Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Antifungal Treatment Market, By Drugs Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
        6. Others

  • 8.   Global Antifungal Treatment Market, By Therapeutic Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use Of Antifungals
        5. Coccidioidomycosis

  • 9.   Global Antifungal Treatment Market, By Pathogen Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton

  • 10.   Global Antifungal Treatment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Dermatology Clinics

  • 11.   North America Antifungal Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Antifungal Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Antifungal Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Antifungal Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Antifungal Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Types Offered and Financial Layouts)
    •   1. Pfizer, Inc.
         1.1. Company Overview
         1.2. Product Type Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Astellas
         2.1. Company Overview
         2.2. Product Type Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Novartis AG.
         3.1. Company Overview
         3.2. Product Type Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. PathoFinder BV
         4.1. Company Overview
         4.2. Product Type Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Merck & Co., Inc.
         5.1. Company Overview
         5.2. Product Type Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bayer AG
         6.1. Company Overview
         6.2. Product Type Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbott
         7.1. Company Overview
         7.2. Product Type Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients